Minerva Neurosciences, Inc. Additional Paid in Capital, Common Stock
Minerva Neurosciences, Inc. (NERV) had Additional Paid in Capital, Common Stock of $583.43 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-07
- 2026-06-30: Additional Paid in Capital, Common Stock $583.43M.
- 2026-03-31: Additional Paid in Capital, Common Stock $560.19M.
- 2025-12-31: Additional Paid in Capital, Common Stock $548.05M.
- 2025-09-30: Additional Paid in Capital, Common Stock $370.55M.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2026-06-30 | $583.43M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $560.19M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $548.05M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $370.55M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $370.28M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $369.98M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $369.68M 10-K · filed 2026-03-11 | |
| 2024-09-30 | $369.43M 10-Q · filed 2024-11-05 | |
| 2024-06-30 | $369.13M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $368.80M 10-Q · filed 2024-05-01 | |
| 2023-12-31 | $368.36M 10-K · filed 2025-02-25 | |
| 2023-09-30 | $367.75M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $367.46M 10-Q · filed 2023-08-01 | |
| 2023-03-31 | $347.16M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $346.79M 10-K · filed 2024-02-22 | |
| 2022-09-30 | $345.84M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $344.80M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $343.73M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $342.68M 10-K · filed 2023-03-08 | $342.67M 10-K · filed 2022-03-01 |
| 2021-09-30 | $341.47M 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $340.35M 10-Q · filed 2021-08-02 | |
| 2021-03-31 | $338.97M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $337.45M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $335.49M 10-Q · filed 2020-11-02 | |
| 2020-06-30 | $326.30M 10-Q · filed 2020-08-03 | |
| 2020-03-31 | $317.51M 10-Q · filed 2020-05-04 | |
| 2019-12-31 | $314.51M 10-K · filed 2021-03-08 | |
| 2019-09-30 | $312.34M 10-Q · filed 2019-11-04 | |
| 2019-06-30 | $310.12M 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $307.80M 10-Q · filed 2019-05-06 | |
| 2018-12-31 | $304.81M 10-K · filed 2020-03-09 | |
| 2018-09-30 | $302.74M 10-Q · filed 2018-11-05 | |
| 2018-06-30 | $299.99M 10-Q · filed 2018-08-02 | |
| 2018-03-31 | $298.09M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $295.98M 10-K · filed 2019-03-12 | |
| 2017-09-30 | $294.72M 10-Q · filed 2017-11-06 | |
| 2017-06-30 | $251.31M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $249.79M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $238.84M 10-K · filed 2018-03-12 | |
| 2016-09-30 | $236.59M 10-Q · filed 2016-11-03 | |
| 2016-06-30 | $235.63M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $176.46M 10-Q · filed 2016-05-03 | |
| 2015-12-31 | $157.13M 10-K · filed 2017-03-13 | |
| 2015-09-30 | $156.44M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $155.81M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $155.26M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $126.23M 10-K · filed 2016-03-14 | |
| 2014-09-30 | $124.00M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $69.37M 10-Q · filed 2014-08-07 | |
| 2013-12-31 | $38.01M 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |